Medicare Enrolled
Dr. Georges Abou Rjaili, MD
Cardiovascular Disease · Riverside, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Abou Rjaili from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Abou Rjaili?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Abou Rjaili
Dr. Georges Abou Rjaili is a cardiovascular disease specialist in Riverside, CA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Abou Rjaili performed 28,120 Medicare services across 2,204 unique beneficiaries.
Between the years covered by Open Payments, Dr. Abou Rjaili received a total of $17,624 from 53 pharmaceutical and/or device companies across 665 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Abou Rjaili is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ Top 1% volume in CA
$17,624 industry payments
Medicare Practice Summary
Medicare Utilization ↗28,120
Medicare services
Top 1% in CA for cardiovascular disease
2,204
Unique beneficiaries
$20
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,009 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Inclisiran injection (Leqvio) for cholesterol | 25,276 | $9 | $28 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
847 | $100 | $341 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
254 | $161 | $548 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
253 | $12 | $39 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
137 | $162 | $530 |
| Nuclear stress test with CT scan A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan. |
127 | $73 | $233 |
| PET scan of heart muscle blood flow A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle. |
127 | $24 | $77 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
126 | $12 | $38 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
93 | $12 | $37 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
80 | $66 | $185 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
65 | $10 | $32 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
60 | $121 | $440 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in one arm or leg using compression and other maneuvers to assess blood flow and check for blockages. |
58 | $104 | $333 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
56 | $159 | $540 |
| Ultrasound guidance for blood vessel access Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood. |
54 | $12 | $37 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
52 | $99 | $266 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
43 | $141 | $516 |
| Mechanochemical vein destruction with imaging guidance A procedure that destroys an incompetent vein in the arm or leg using mechanical and chemical methods while guided by imaging. |
39 | $1,048 | $3,816 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
34 | $69 | $240 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
34 | $176 | $567 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
33 | $21 | $67 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
33 | $719 | $1,908 |
| Ultrasound-guided injection into a single leg vein A chemical agent is injected into one incompetent vein in the leg while using ultrasound to guide the needle placement. |
30 | $1,153 | $3,592 |
| Cardiac catheterization | 29 | $205 | $763 |
| Ultrasound of abdominal aorta An imaging test that uses sound waves to create pictures of the abdominal aorta, the large blood vessel that carries blood from the heart to the lower body. |
27 | $116 | $297 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
25 | $88 | $282 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
25 | $15 | $47 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
25 | $3 | $8 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
20 | $104 | $351 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 19 | $278 | $970 |
| Intravascular ultrasound of heart vessel, initial An ultrasound procedure used to evaluate a blood vessel within the heart during a diagnostic or treatment procedure. |
14 | $59 | $189 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
13 | $53 | $209 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
12 | $151 | $475 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.1% high complexity
92.8% medium
6.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$17,624
Total received (2018-2024)
Avg $2,518/year across 7 years
Top 19% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
665
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,586 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$38 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,545
2023
$2,015
2022
$2,010
2021
$1,575
2020
$1,399
2019
$3,876
2018
$3,205
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$1,469
Novartis Pharmaceuticals Corporation
$360
AstraZeneca Pharmaceuticals LP
$272
Merck Sharp & Dohme LLC
$202
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$188
Boehringer Ingelheim Pharmaceuticals, Inc.
$153
Alnylam Pharmaceuticals Inc.
$141
Esperion Therapeutics, Inc.
$139
PFIZER INC.
$120
Amgen Inc.
$104
E.R. Squibb & Sons, L.L.C.
$70
Philips North America LLC
$62
Novo Nordisk Inc
$54
SCPHARMACEUTICALS INC.
$39
Abbott Laboratories
$33
Bayer Healthcare Pharmaceuticals Inc.
$31
Kiniksa Pharmaceuticals International, plc
$27
Boston Scientific Corporation
$26
Inspire Medical Systems, Inc.
$19
Inari Medical, Inc.
$19
Janssen Pharmaceuticals, Inc
$17
Top 3 companies account for 59.3% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic, Inc.
$1,999
ABIOMED
$1,831
Medtronic Vascular, Inc.
$1,564
Novartis Pharmaceuticals Corporation
$1,549
Abbott Laboratories
$1,220
AstraZeneca Pharmaceuticals LP
$1,102
Amgen Inc.
$845
Boehringer Ingelheim Pharmaceuticals, Inc.
$707
E.R. Squibb & Sons, L.L.C.
$697
Merck Sharp & Dohme LLC
$627
SANOFI-AVENTIS U.S. LLC
$620
Alnylam Pharmaceuticals Inc.
$570
Janssen Pharmaceuticals, Inc
$453
Esperion Therapeutics, Inc.
$402
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$400
PFIZER INC.
$375
Regeneron Healthcare Solutions, Inc.
$259
Amarin Pharma Inc.
$250
Novo Nordisk Inc
$182
Gilead Sciences, Inc.
$182
Boston Scientific Corporation
$136
ShockWave Medical, Inc
$136
Acutus Medical, Inc.
$131
Daiichi Sankyo Inc.
$118
Kowa Pharmaceuticals America, Inc.
$96
Philips Electronics North America Corporation
$95
CVRx, Inc.
$83
SCPHARMACEUTICALS INC.
$67
Bayer Healthcare Pharmaceuticals Inc.
$65
Relypsa, Inc.
$63
Philips North America LLC
$62
Actelion Pharmaceuticals US, Inc.
$58
Kiniksa Pharmaceuticals, Ltd.
$56
ARBOR PHARMACEUTICALS, INC.
$54
BIOTRONIK INC.
$49
Akcea Therapeutics, Inc.
$46
Merck Sharp & Dohme Corporation
$44
Astellas Pharma US Inc
$43
Terumo Medical Corporation
$41
ARALEZ PHARMACEUTICALS US INC.
$40
Allergan Inc.
$36
Acist Medical Systems, Inc.
$32
Bardy Diagnostics, Inc.
$29
Baxter Healthcare
$29
Kiniksa Pharmaceuticals International, plc
$27
Arbor Pharmaceuticals, Inc.
$26
Cardiovascular Systems Inc.
$24
BOSTON SCIENTIFIC CORPORATION
$20
Inspire Medical Systems, Inc.
$19
Inari Medical, Inc.
$19
Braemar Manufacturing, LLC
$18
W. L. Gore & Associates, Inc.
$16
Avinger Inc.
$13
Top 3 companies account for 30.6% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (7999) SRC Undivided · (P77) Azurion 7 M20 · AMVUTTRA · ARCTIC FRONT ADVANCE · Arcalyst · Azure · BELSOMRA · BIOMONITOR · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CARDIOFORM Septal Occluder · CARDIOMEMS · CHANTIX · COREVALVE EVOLUT R · Cardiac Monitoring Suite · Carnation Ambulatory Monitor · Cobalt · CoreValve Evolut · Corlanor · Diamondback Peripheral · ELIQUIS · ENTRESTO · EVKEEZA · Edarbi · Edarbyclor · FARXIGA · FLOWTRIEVER CATHETER · FUROSCIX · GLIDESHEATH SLENDER · Glidesheath · HD-IVUS · Hillrom - Cardiac Ambulatory Monitor · INJECTAFER · INSPIRE · Impella · JARDIANCE · Kerendia · LEQVIO · LEXISCAN · LINQ II · LifeVest · Livalo · MULTAQ · Micra · Mitra Clip system · NEXLETOL · ONPATTRO · OPSUMIT · Ozempic · PANTHERIS · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Repatha · Rybelsus · S · STEGLATRO · TEGSEDI · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · Vascular Lithotripsy · Veltassa · Victoza · WAINUA · WATCHMAN · WATCHMAN Access System · XARELTO · XIENCE SKYPOINT · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
105
Per 100K population
4.3
County median income
$89,672
Nearest hospital
RIVERSIDE COMMUNITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Abou Rjaili is a mixed practice specialist, with above-average Medicare volume (top 1% in CA), with low-engagement industry engagement in the top 19% of CA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Abou Rjaili experienced with inclisiran injection (leqvio) for cholesterol?
Based on Medicare claims data, Dr. Abou Rjaili performed 25,276 inclisiran injection (leqvio) for cholesterol services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Abou Rjaili receive payments from pharmaceutical companies?
Yes. Dr. Abou Rjaili received a total of $17,624 from 53 companies across 665 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Abou Rjaili's costs compare to other cardiologists in Riverside?
Dr. Abou Rjaili's average Medicare payment per service is $20. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Abou Rjaili) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Riverside
Browse cardiologists in Riverside ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
ABIOMED Payments to Doctors
See all physicians who received payments from ABIOMED.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology